Kollmannsberger, C., & Bokemeyer, C. (2003). Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group. Nature Publishing Group.
Chicago Stili AlıntıKollmannsberger, C., ve C. Bokemeyer. Reply: Irinotecan in Patients With Relapsed or Cisplatin-refractory Germ Cell Cancer: A Phase II Study of the German Testicular Cancer Study Group. Nature Publishing Group, 2003.
MLA AlıntıKollmannsberger, C., ve C. Bokemeyer. Reply: Irinotecan in Patients With Relapsed or Cisplatin-refractory Germ Cell Cancer: A Phase II Study of the German Testicular Cancer Study Group. Nature Publishing Group, 2003.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..